These include ACVR1 mutations (~30% of DIPG tumors) and co-occur with H3.1 and TP53 mutations (~22–40% of DIPG tumors) which co-occur with PDFR amplification [48,49,50]. This evidence concerns the gene TP53 and diffuse intrinsic pontine glioma.